Company news
Stimcell Energetics Inc. (OTC:STME) news
Stimcell Energetics Inc. news releases on 6ix. Latest, Sep 8, 2026: StimCell Energetics Engages Stonegate Capital Markets as Non-Exclusive Advisor…
Press releases & updates
StimCell Energetics Engages Stonegate Capital Markets as Non-Exclusive Advisor for Strategic Capital Market Transactions
September 8, 2026
Stonegate Initiates Coverage on StimCell Energetics Inc. (STME)
May 15, 2026
StimCell Energetics Engages Stonegate Capital Partners for Research Coverage and Institutional Investor Outreach
March 19, 2026
StimCell Energetics Inc. Announces Study into eBalance(R) Device's Impact on Neuronal Mitochondrial Function
December 2, 2025
OTC Markets Group Welcomes New OTCQB Companies – October 27
October 26, 2025
StimCell Energetics Inc. Successfully Uplists to OTCQB Market
October 24, 2025
StimCell Energetics Provides Sneak Peek at eBalance Redesign Progress and Announces Shares for Debt Transaction and the Engagement of Independent Investor Relations Consultant
March 26, 2025
StimCell Energetics Partners With ADM Tronics to Redesign eBalance Microcurrent Device for Home Use
February 25, 2025
Cell MedX Corp: Letter to Shareholders from Mr. Dwayne Yaretz, CEO
June 26, 2022
Cell MedX Corp. Appoints Mr. Dwayne Yaretz as CEO and Director
April 26, 2022
Cell MedX Corp. to Attend the 29th Annual Wellness Show 2022 Held in Vancouver, BC
March 23, 2022
FDA Commences Review of Cell MedX's Premarket Notification (510K) and Health Canada Renews Class II Medical Device Licenses for eBalance(R) Systems
November 14, 2021
Cell MedX Corp. Files Premarket Notification (510K) with the US Food and Drug Administration and Receives Canadian Trademark
September 16, 2021
Cell MedX Corp. Converts Debt to Shares, Closes Non-brokered Private Placement Financing, and Engages Investor Relations Consultants
May 26, 2021
Cell MedX Corp.’s eBalance Pro System Receives Class II Medical Device License from Health Canada
August 31, 2020
Cell MedX Corp. (CMXC) Closes Non-Brokered Private Placement Financing
August 3, 2020
Cell MedX Corp. Files Two Applications for Class II Medical Device Licenses with Health Canada
July 6, 2020
Cell MedX Corp. Receives Quality Management System ISO 13485:2016 MDSAP Certificate
June 9, 2020
Cell MedX Corp. Receives Quality Management System ISO 13485:2016 Certificate for the eBalance® Device
April 6, 2020
Cell MedX Corp. Reacquires World Wide Exclusivity Rights for the eBalanceⓇ Device
January 29, 2020
Cell MedX Corp. Engages Dr. Peter Eppinga as Lead Investigator in the eBalanceⓇ R&D Experience Study
December 12, 2019
Cell MedX Corp. Receives eBalance Trademark
October 17, 2019
Cell MedX Corp. Provides Corporate Update
September 12, 2019
CellMedX Corp. Receives Approval to Commence Family Practice (BC) Observational Study
August 19, 2019
Cell MedX Corp. (CMXC) Closes the First Tranche of its Non-brokered Private Placement Financing
June 27, 2019
Cell MedX Corp. Engages Think Ink Marketing
June 20, 2019
Cell MedX Corp. (CMXC) Arranges a Non-brokered Private Placement Financing
May 30, 2019
Cell MedX signs Definitive Worldwide Distribution Rights Agreement with Live Current Media, Inc.
March 26, 2019
Cell MedX Corp. Provides an Update on Progress Toward US Premarket Clearance and Clarifies its eBalance Certification
February 12, 2019
Cell MedX Corp. Enters into Credit Line Agreement and Issues Warrants
December 31, 2018
Cell MedX Corp. Receives Safety and Electrical Certifications for the eBalance Pro Device
December 4, 2018
Cell MedX Corp signs Letter of Intent for Worldwide Distribution Rights and enters into Royalty Agreement Contracts
September 13, 2018
Dr. Terrance Owen Resigns as CEO of Cell MedX Corp
May 6, 2018
Cell MedX Corp. Appoints Dr. George Adams as Director
March 26, 2018
December 5, 2017; Cell MedX Corp. Appoints Dr. Terrance Owen as CEO and Director
January 30, 2018
Cell MedX Corp. provides additional information on its observational clinical trial with diabetes and related conditions
January 29, 2018
Cell MedX Corp. Assigned Legal Entity Identifier Number
January 28, 2018
Cell MedX Corp. completes its first observational clinical trial and observes
January 23, 2018
Cell MedX (CMXC) Widens Scope for Breakthrough Technology -- SECFilings.com
December 13, 2016
Cell MedX (CMXC) Advances the Power of Microcurrents -- SECFilings.com
November 29, 2016
Cell MedX Corp. Appoints Gregory Pek to the Advisory Board and as a Distributor
November 21, 2016
Cell MedX Corp. (CMXC) Cancels Options and Appoints a Director
September 29, 2016
Cell MedX Corp. (CMXC) Provides Corporate Update
July 14, 2016
Cell MedX Corp. (CMXC) Engages Nutrasource Diagnostics Inc. to Commence Clinical Trials in Canada
March 22, 2016
Cell MedX Corp. Signs a Loan Agreement
March 9, 2016
Cell MedX Corp. Introduces Ongoing eBalance Pro Trial Observations Online
January 25, 2016
Cell MedX Corp. Rolls Out eBalance Pro Series Device for Diabetes Research
January 11, 2016
Cell MedX Corp. Adds Team Members as Report of New Study on US Diabetes Growth Emerges
September 16, 2015
Cell MedX Corp. (CMXC) Enters Into an Option Agreement With Its President and CEO
August 11, 2015
Cell MedX Corp. (CMXC) Initiates Discussions With Industry Specialists at Worrell Design
August 4, 2015